North. poster Marz is is saying that its your view that that the FDA can not approve Hikma's ANDA because it would conflict with the R-IT patent .......if I'm understanding him.
Can You clarify ?
On what basis would the FDA deny their ANDA beyond the normal requirements re quality of manufacturing etc etc Kiwi
News 
Market Data 
Discover 
AI
